Evidence map›Paper›PMID 36142002›Full record

ReviewInternational journal of environmental research and public health2022

The Trends and Hotspots in Premature Ovarian Insufficiency Therapy from 2000 to 2022.

Yan Tong, Nan Cheng, Xinran Jiang, Kai Wang, Fei Wang, Xinxin Lin, Fang Wang

Abstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Women's Health and Gynecology: Old Challenges and New Insights.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yan TongDepartment of Literature and Information of Library, Shenyang Pharmaceutical University, Shenyang 110016, China.
Nan ChengSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.
Xinran JiangSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Kai WangSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.
Fei WangSchool of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang 110016, China.
Xinxin LinSchool of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang 110016, China.
Fang WangSchool of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang 110016, China.ORCID 0000-0003-4424-3728

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to map the knowledge structure and themes trends of primary ovarian insufficiency (POI) therapy to help researchers rapidly master the hotspots and prospects of POI therapy from the increasing number of publications. The literature search and bibliometric analyses were performed by using Web of Science Core Collection and VOSviewer. Annual publications from 2000 to 2022 continued to increase with some fluctuations. The most productive country, organization, and journal were the USA, Shanghai Jiao Tong University, and

Indexed as

Biomedical ResearchBibliometricsChinaEfficiencyHumansPublicationsbibliometric analysisprimary ovarian insufficiencyscience mappingtherapy

Identifiers

PMID36142002
PMCPMC9517308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.